|
| 3-Methylthio-1,4-diphenyl-1H-1,3,4-triazolium |
|
Escherichia |
Heat-labile toxin (LT) |
In vivo |
|
| (3R)-5-Oxo-6-(dimethylaminomethyl)-7-(1-naphthylmethyl)-8-phenyl-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3beta-carboxylic acid lithium salt |
|
Escherichia |
Type 1 fimbriae; P fimbriae |
In vivo |
|
| L-ascorbic acid |
|
Klebsiella |
Biofilm |
In vivo |
|
| 7-hydroxyindole |
|
Pseudomonas |
Biofilm |
In vivo |
|
| Indole |
|
Pseudomonas |
Biofilm |
In vivo |
|
| 4-methyl-2-(4-methylphenyl)-6-{5-[(4-phenylpiperazin-1-yl)carbonyl]-1,2,4-oxadiazol-3-yl}-1,2,4-triazine-3,5(2H,4H)-dione |
|
Shigella |
TTSS (Type III secretion system) |
In vivo |
|
| 4-methyl-2-phenyl-6-{5-[(4-phenylpiperazin-1-yl)carbonyl]-1,2,4-oxadiazol-3-yl}-1,2,4-triazine-3,5(2H,4H)-dione |
|
Shigella |
TTSS (Type III secretion system) |
In vivo |
|
| 6-(4-((2,4-dimethylphenyl)sulfonyl)piperazin-1-yl)-N-(pyridin-4-yl)pyridazin-3-amine |
|
Shigella |
TTSS (Type III secretion system) |
In vivo |
|
| N-(1,3-benzodioxol-5-ylmethyl)-1-[(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-7-yl)sulfonyl]-4-piperidinecarboxamide |
|
Shigella |
TTSS (Type III secretion system) |
In vivo |
|
| N-(furan-2-ylmethylcarbamoyl)-2-(4-oxobenzo[g]quinazolin-3-yl)acetamide |
|
Shigella |
TTSS (Type III secretion system) |
In vivo |
|
| | | |
